NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $232,356 | -70.2% | 330,568 | -4.0% | 0.00% | -66.7% |
| Q4 2022 | $778,480 | +70542.5% | 344,460 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $1,102 | -99.9% | 344,460 | 0.0% | 0.01% | -18.2% |
| Q2 2022 | $1,309,000 | -29.5% | 344,460 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $1,857,000 | -63.4% | 344,460 | -8.4% | 0.01% | -59.3% |
| Q4 2021 | $5,078,000 | +727.0% | 375,900 | +1015.0% | 0.03% | +575.0% |
| Q3 2019 | $614,000 | -24.3% | 33,712 | +47.9% | 0.00% | -42.9% |
| Q2 2019 | $811,000 | +66.5% | 22,800 | +57.2% | 0.01% | +75.0% |
| Q1 2019 | $487,000 | +66.2% | 14,500 | +62.9% | 0.00% | +100.0% |
| Q4 2018 | $293,000 | -84.2% | 8,900 | -70.7% | 0.00% | -84.6% |
| Q3 2018 | $1,853,000 | +322.1% | 30,400 | +237.8% | 0.01% | +333.3% |
| Q2 2018 | $439,000 | -54.1% | 9,000 | 0.0% | 0.00% | -57.1% |
| Q1 2018 | $956,000 | -83.9% | 9,000 | -90.9% | 0.01% | -82.1% |
| Q4 2017 | $5,928,000 | +152.9% | 99,255 | +1.6% | 0.04% | +290.0% |
| Q3 2017 | $2,344,000 | +51.0% | 97,655 | +23.0% | 0.01% | -23.1% |
| Q2 2017 | $1,552,000 | -40.3% | 79,400 | -28.3% | 0.01% | -45.8% |
| Q1 2017 | $2,598,000 | +94.8% | 110,700 | +1.8% | 0.02% | +84.6% |
| Q4 2016 | $1,334,000 | -19.5% | 108,700 | +12.6% | 0.01% | -23.5% |
| Q3 2016 | $1,658,000 | +20.8% | 96,500 | 0.0% | 0.02% | +13.3% |
| Q2 2016 | $1,373,000 | +6.2% | 96,500 | +2.7% | 0.02% | +7.1% |
| Q1 2016 | $1,293,000 | -18.4% | 94,000 | 0.0% | 0.01% | +7.7% |
| Q4 2015 | $1,584,000 | -0.8% | 94,000 | -35.5% | 0.01% | -7.1% |
| Q3 2015 | $1,597,000 | -36.2% | 145,700 | -27.2% | 0.01% | -22.2% |
| Q2 2015 | $2,502,000 | – | 200,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |